• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用药依从性的隐形监测:特应性皮炎患儿的依从性非常差。

Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis.

作者信息

Krejci-Manwaring Jennifer, Tusa Mark G, Carroll Christie, Camacho Fabian, Kaur Mandeep, Carr David, Fleischer Alan B, Balkrishnan Rajesh, Feldman Steven R

机构信息

Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1071, USA.

出版信息

J Am Acad Dermatol. 2007 Feb;56(2):211-6. doi: 10.1016/j.jaad.2006.05.073. Epub 2006 Nov 13.

DOI:10.1016/j.jaad.2006.05.073
PMID:17224366
Abstract

BACKGROUND

Atopic dermatitis is a common problem for which topical agents are the primary treatment. When topical medications fail, further therapy may include systemic agents with the potential for greater toxicity. Adherence to topical treatment of atopic dermatitis has not been well characterized. Poor adherence to topical medication could account for failure of topical therapy.

PURPOSE

To determine adherence to topical treatment in patients with atopic dermatitis.

METHODS

Thirty-seven children were given 0.1% triamcinolone ointment and were counseled to use it twice daily. They were told to return in 4 weeks, at which time they were told to continue treatment for another 4 weeks. Electronic monitors were used to measure adherence over the entire 8 week study. Patients were not informed of the compliance monitoring until the end of the study.

RESULTS

Twenty-six patients completed 8 weeks of treatment. Mean adherence from the baseline to the end of the study was 32%. Adherence was higher on or near office visit days and subsequently decreased rapidly.

LIMITATIONS

This study was limited by the large number of subjects who failed to return for follow-up appointments or withdrew from the study.

CONCLUSIONS

Adherence to topical medications is very poor in a clinic population of children with atopic dermatitis. Office visits are one means to increase adherence. If adherence to topical treatment can be improved, exposure to more costly and potentially toxic systemic agents may be avoidable.

摘要

背景

特应性皮炎是一个常见问题,局部用药是主要治疗方法。当局部用药无效时,进一步治疗可能包括毒性更大的全身性药物。特应性皮炎局部治疗的依从性尚未得到充分描述。局部用药依从性差可能是局部治疗失败的原因。

目的

确定特应性皮炎患者局部治疗的依从性。

方法

37名儿童被给予0.1%曲安奈德软膏,并建议每日使用两次。告知他们4周后复诊,届时再告知他们继续治疗4周。在整个8周的研究中使用电子监测器测量依从性。直到研究结束患者才被告知有依从性监测。

结果

26名患者完成了8周的治疗。从基线到研究结束的平均依从性为32%。在复诊日或复诊日前后依从性较高,随后迅速下降。

局限性

本研究受到大量未返回进行随访预约或退出研究的受试者的限制。

结论

在临床的特应性皮炎儿童群体中,局部用药的依从性非常差。复诊是提高依从性的一种方法。如果能提高局部治疗的依从性,或许可以避免使用更昂贵且有潜在毒性的全身性药物。

相似文献

1
Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis.局部用药依从性的隐形监测:特应性皮炎患儿的依从性非常差。
J Am Acad Dermatol. 2007 Feb;56(2):211-6. doi: 10.1016/j.jaad.2006.05.073. Epub 2006 Nov 13.
2
Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease.尽管患有严重的特应性皮炎,但外用糖皮质激素的依从性仍较差。
Dermatol Online J. 2008 Sep 15;14(9):13.
3
Adherence to topical therapy increases around the time of office visits.在门诊就诊期间,局部治疗的依从性会有所提高。
J Am Acad Dermatol. 2007 Jul;57(1):81-3. doi: 10.1016/j.jaad.2007.04.005. Epub 2007 May 10.
4
Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.使用地奈德水凝胶治疗特应性皮炎的良好依从性和早期疗效:一项针对患者依从性项目的结果
J Drugs Dermatol. 2010 Apr;9(4):324-9.
5
Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.外用他克莫司和外用糖皮质激素序贯应用治疗儿童特应性皮炎的疗效:一项开放标签的试点研究。
J Am Acad Dermatol. 2009 Feb;60(2):212-7. doi: 10.1016/j.jaad.2008.09.034. Epub 2008 Nov 22.
6
Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.1997 - 2004年美国儿童特应性皮炎:就诊趋势、患者及医疗服务提供者特征与处方模式
Pediatrics. 2007 Sep;120(3):e527-34. doi: 10.1542/peds.2007-0289.
7
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.每周三次使用他克莫司软膏可减少稳定期特应性皮炎的复发:一种新的使用模式。
Pediatrics. 2008 Dec;122(6):e1210-8. doi: 10.1542/peds.2008-1343. Epub 2008 Nov 17.
8
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.通过电子方式监测使用特拉万给药辅助装置的青光眼局部用药依从性的研究。
Ophthalmology. 2009 Feb;116(2):191-9. doi: 10.1016/j.ophtha.2008.09.004. Epub 2008 Dec 12.
9
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.他克莫司软膏治疗儿童特应性皮炎的长期安全性和有效性。
Acta Derm Venereol. 2007;87(1):54-61. doi: 10.2340/00015555-0167.
10
Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies.复诊时间对特应性皮炎患者局部治疗依从性的影响:5项研究的分析
Cutis. 2013 Feb;91(2):105-7.

引用本文的文献

1
Predictors of Topical Corticosteroid Adherence Among Caregivers of Children with Atopic Eczema.特应性皮炎患儿照料者局部使用皮质类固醇激素依从性的预测因素
Patient Prefer Adherence. 2025 May 29;19:1593-1601. doi: 10.2147/PPA.S498527. eCollection 2025.
2
Adherence to oral and topical medications among dermatology patients.皮肤科患者对口服和外用药物的依从性。
Arch Dermatol Res. 2025 Mar 20;317(1):609. doi: 10.1007/s00403-025-03952-2.
3
Management Strategies and Corticophobia among Healthcare Professionals Involved in the Care for Atopic Dermatitis: A Dutch Survey.
参与特应性皮炎护理的医护人员的管理策略与皮质类固醇恐惧症:一项荷兰调查
Dermatology. 2025;241(2):101-112. doi: 10.1159/000542421. Epub 2024 Nov 4.
4
Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates.常见皮肤病治疗依从性的当前见解及优化依从率的策略
Cureus. 2024 Sep 19;16(9):e69764. doi: 10.7759/cureus.69764. eCollection 2024 Sep.
5
Medicaid coverage for nonsteroidal topical atopic dermatitis treatment is often restrictive and variable across the United States.在美国,医疗补助对非甾体类外用特应性皮炎治疗的覆盖范围往往具有局限性且存在差异。
Arch Dermatol Res. 2024 Jun 15;316(7):406. doi: 10.1007/s00403-024-03165-z.
6
Adherence in Atopic Dermatitis.特应性皮炎的依从性。
Adv Exp Med Biol. 2024;1447:169-190. doi: 10.1007/978-3-031-54513-9_15.
7
Brief parenting intervention (Triple P) for families of children with eczema: a randomized controlled trial.针对湿疹儿童家庭的简短育儿干预(三级预防项目):一项随机对照试验。
J Pediatr Psychol. 2024 Jun 13;49(6):429-441. doi: 10.1093/jpepsy/jsae023.
8
Readability of Patient Electronic Materials for Atopic Dermatitis in 23 Languages: Analysis and Implications for Dermatologists.23种语言的特应性皮炎患者电子资料的可读性:对皮肤科医生的分析与启示
Dermatol Ther (Heidelb). 2024 Mar;14(3):671-684. doi: 10.1007/s13555-024-01115-1. Epub 2024 Feb 24.
9
Update on the advances and challenges in bioequivalence testing methods for complex topical generic products.复杂局部用仿制药生物等效性测试方法的进展与挑战综述
Front Pharmacol. 2024 Feb 8;15:1330712. doi: 10.3389/fphar.2024.1330712. eCollection 2024.
10
Transepidermal Water Loss and T-helper 2 (Th2)-Associated Inflammatory Markers in Two Pediatric Patients During the First Four Weeks of Treatment With the Oral Janus Kinase Inhibitor Upadacitinib.两名儿科患者在口服JAK抑制剂乌帕替尼治疗的前四周期间的经表皮水分流失及与辅助性T细胞2(Th2)相关的炎症标志物
Cureus. 2023 Dec 27;15(12):e51196. doi: 10.7759/cureus.51196. eCollection 2023 Dec.